Cassava Sciences, Inc.
SAVA
|
$16.64
-1.31%
-1.32%
730K
|
Health Technology
(0.0% 1d) (-20.6% 1m) (-59.9% 1y) (-1.3% 2d) (-1.8% 3d) (-6.6% 7d) (39.02% volume)
Earnings Calendar: 2023-08-03
Market Cap: $ 698,380,700
http://www.cassavasciences.com
Sec Filling | Patents | 9 employees
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.
alzheimer diagnostics treatment alzheimer’s
add to watch list email alert is off
Press-releases
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
Published: 2023-09-18 (Crawled : 13:00) - globenewswire.com
SAVA | $16.64 -1.31% -1.32% 730K
|
Health Technology
|
| O: 4.02%
H: 0.3%
C: -8.96%
disease alzheimer’s review positive trials sciences
Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimer’s Disease
Published: 2023-09-13 (Crawled : 21:00) - globenewswire.com
SAVA | $16.64 -1.31% -1.32% 730K
|
Health Technology
|
| O: 0.77%
H: 4.73%
C: 0.0%
drug candidate disease alzheimer’s publication sciences
Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimer’s Disease
Published: 2023-09-11 (Crawled : 13:00) - globenewswire.com
SAVA | $16.64 -1.31% -1.32% 730K
|
Health Technology
|
| O: 0.71%
H: 2.78%
C: -1.51%
drug candidate disease alzheimer’s publication sciences
Cassava Sciences Invited to Present in Four Upcoming Investor Conferences
Published: 2023-09-06 (Crawled : 13:00) - globenewswire.com
SAVA | $16.64 -1.31% -1.32% 730K
|
Health Technology
|
| O: -0.52%
H: 1.86%
C: -1.63%
sciences
Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates
Published: 2023-08-03 (Crawled : 13:20) - globenewswire.com
SAVA | $16.64 -1.31% -1.32% 730K
|
Health Technology
|
| O: -1.53%
H: 2.13%
C: 0.87%
sciences financial results
Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and Company, Janssen, Merck, BioVie, Biogen, Vivoryon, Sage, Alnylam, BioXcel, EIP, Otsuka, Alector, Transposon
Published: 2023-07-26 (Crawled : 21:00) - prnewswire.com
COYA | $3.835 -6.92% -7.43% 28K
|
|
| O: 0.0%
H: 1.87%
C: 0.5%
LLY | $537.13 -1.34% 0.14% 2.9M
|
Health Technology
|
| O: -0.06%
H: 1.18%
C: 0.37%
SEEL | $0.183 3.22% 3.11% 5.2M
|
Health Technology
|
| O: 1.48%
H: 0.73%
C: -2.19%
PRTA M | $48.19 -1.31% -1.33% 300K
|
Health Technology
|
| O: 1.08%
H: 2.08%
C: 1.79%
PASG | $0.66 -0.3% -0.3% 140K
|
Health Technology
|
| O: 3.33%
H: 0.0%
C: -8.82%
IONS S | $45.35 -1.97% -2.01% 1.3M
|
Health Technology
|
| O: 0.33%
H: 0.13%
C: -1.56%
DNLI | $20.61 -1.67% -1.7% 900K
|
Health Technology
|
| O: 1.22%
H: 0.0%
C: -1.42%
SAVA | $16.64 -1.31% -1.32% 730K
|
Health Technology
|
| O: 0.6%
H: 1.74%
C: 1.24%
BIVI | $3.46 9.15% 8.38% 170K
|
Health Technology
|
| O: 0.43%
H: 0.85%
C: -2.12%
AXSM | $69.83 -4.42% -4.63% 730K
|
Health Technology
|
| O: 0.56%
H: 3.6%
C: 0.99%
companies active dementia market
Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimer’s Disease
Published: 2023-07-05 (Crawled : 13:00) - globenewswire.com
SAVA | $16.64 -1.31% -1.32% 730K
|
Health Technology
|
| O: 4.27%
H: 3.07%
C: -16.52%
disease alzheimer’s trial
New Research Shows Simufilam Suppresses Overactive mTOR
Published: 2023-06-27 (Crawled : 13:20) - globenewswire.com
SAVA | $16.64 -1.31% -1.32% 730K
|
Health Technology
|
| O: 0.8%
H: 1.97%
C: 0.84%
research
New Publication Highlights Basic Science Supporting Simufilam
Published: 2023-06-12 (Crawled : 13:20) - globenewswire.com
SAVA | $16.64 -1.31% -1.32% 730K
|
Health Technology
|
| O: 1.36%
H: 5.52%
C: 0.12%
publication
Cassava Sciences to Present at the Jefferies Global Healthcare Conference
Published: 2023-06-01 (Crawled : 13:20) - globenewswire.com
SAVA | $16.64 -1.31% -1.32% 730K
|
Health Technology
|
| O: 0.22%
H: 2.06%
C: -1.05%
conference sciences global
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 66% | 34% |
Top 10 Gainers
Last 48 Hours Insiders Buying
TWN P 1000 | $37.75 0%
|
Miscellaneous
|
23:00
NMRA P 69120 new | $14.1 6.66% 6.24% 360K
|
|
23:00
FPI P 31048 | $10.26 0.0% 370K
|
Finance
|
22:00
FOMC A 10000 | $0.0002 -33.33% 7.4M
|
Wholesale Trade
|
16:02
GUG P 1784 | $13.5 0.3% 0.0% 72K
|
|
15:00
RMCF | $4.81 1.26% 1.25% 3.6K
|
Consumer Non-Durables
|
20:10
HPKEW 4 | $10.25 0%
|
Industrial Services
|
23:50